FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167524512> ?p ?o ?g. }

• W2167524512 endingPage "603" @default.
• W2167524512 startingPage "598" @default.
• W2167524512 abstract "Men with chronic renal failure evaluated for transplantation are often tested for prostate specific antigen (PSA) to detect prostate cancer. PSA occurs in several different molecular forms in serum: free PSA (fPSA) and complexed PSA (cPSA), the sum of which corresponds to total PSA (tPSA). In addition to tPSA, percent fPSA to tPSA (%fPSA) is widely used to enhance discrimination of benign disorders from prostate cancer. The low molecular mass of fPSA suggests elimination by renal glomerular filtration and that renal failure may significantly influence %fPSA. We evaluated whether established reference levels for %fPSA are applicable also to patients treated with haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).The study included 20 men on intermittent haemodialysis with low-flux membranes and 25 men on CAPD, without known history of prostate cancer. The control group included 3129 men without known prostate cancer. We analysed fPSA and tPSA in serum by dual-label immunofluorometric assays, from which we calculated %fPSA and cPSA. Serum levels of different PSA forms were adjusted for age and presented as geometric means.Percent fPSA was significantly higher in patients on either haemodialysis (39.5%) or CAPD (39.6%) compared with controls (28.1%). Haemodialysis patients, but not CAPD patients, had significantly higher mean levels of fPSA. Levels of tPSA and cPSA for haemodialysis or CAPD patients did not differ significantly compared with controls.Recommended reference ranges for %fPSA, based on men with normal renal function, do not apply to uraemic men on dialysis. In these men, a high %fPSA should not be considered as a sign of benign disease. This is clinically important in the evaluation of dialysis patients for transplantation, as %fPSA is often used as a tool for detection of prostate cancer." @default.
• W2167524512 created "2016-06-24" @default.
• W2167524512 creator A5002541798 @default.
• W2167524512 creator A5020495334 @default.
• W2167524512 creator A5039182141 @default.
• W2167524512 creator A5056770711 @default.
• W2167524512 creator A5073708805 @default.
• W2167524512 creator A5080395405 @default.
• W2167524512 date "2003-03-01" @default.
• W2167524512 modified "2023-10-12" @default.
• W2167524512 title "Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment" @default.
• W2167524512 cites W1845134010 @default.
• W2167524512 cites W1847856759 @default.
• W2167524512 cites W197591860 @default.
• W2167524512 cites W1980495379 @default.
• W2167524512 cites W1984103570 @default.
• W2167524512 cites W2004024108 @default.
• W2167524512 cites W2004499699 @default.
• W2167524512 cites W2006646189 @default.
• W2167524512 cites W2008374734 @default.
• W2167524512 cites W2027084493 @default.
• W2167524512 cites W2032369727 @default.
• W2167524512 cites W2038315988 @default.
• W2167524512 cites W2063122013 @default.
• W2167524512 cites W2067535120 @default.
• W2167524512 cites W2068836981 @default.
• W2167524512 cites W2082865888 @default.
• W2167524512 cites W2088987414 @default.
• W2167524512 cites W2090530819 @default.
• W2167524512 cites W2139263246 @default.
• W2167524512 cites W2235954515 @default.
• W2167524512 cites W2270969389 @default.
• W2167524512 cites W2421062146 @default.
• W2167524512 cites W262100597 @default.
• W2167524512 cites W2942956196 @default.
• W2167524512 doi "https://doi.org/10.1093/ndt/18.3.598" @default.
• W2167524512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12584285" @default.
• W2167524512 hasPublicationYear "2003" @default.
• W2167524512 type Work @default.
• W2167524512 sameAs 2167524512 @default.
• W2167524512 citedByCount "52" @default.
• W2167524512 countsByYear W21675245122012 @default.
• W2167524512 countsByYear W21675245122013 @default.
• W2167524512 countsByYear W21675245122014 @default.
• W2167524512 countsByYear W21675245122015 @default.
• W2167524512 countsByYear W21675245122016 @default.
• W2167524512 countsByYear W21675245122017 @default.
• W2167524512 countsByYear W21675245122020 @default.
• W2167524512 countsByYear W21675245122021 @default.
• W2167524512 countsByYear W21675245122023 @default.
• W2167524512 crossrefType "journal-article" @default.
• W2167524512 hasAuthorship W2167524512A5002541798 @default.
• W2167524512 hasAuthorship W2167524512A5020495334 @default.
• W2167524512 hasAuthorship W2167524512A5039182141 @default.
• W2167524512 hasAuthorship W2167524512A5056770711 @default.
• W2167524512 hasAuthorship W2167524512A5073708805 @default.
• W2167524512 hasAuthorship W2167524512A5080395405 @default.
• W2167524512 hasConcept C121608353 @default.
• W2167524512 hasConcept C126322002 @default.
• W2167524512 hasConcept C126894567 @default.
• W2167524512 hasConcept C159641895 @default.
• W2167524512 hasConcept C2776235491 @default.
• W2167524512 hasConcept C2779056158 @default.
• W2167524512 hasConcept C2779978075 @default.
• W2167524512 hasConcept C2780192828 @default.
• W2167524512 hasConcept C2781406297 @default.
• W2167524512 hasConcept C2909406889 @default.
• W2167524512 hasConcept C35785553 @default.
• W2167524512 hasConcept C71924100 @default.
• W2167524512 hasConceptScore W2167524512C121608353 @default.
• W2167524512 hasConceptScore W2167524512C126322002 @default.
• W2167524512 hasConceptScore W2167524512C126894567 @default.
• W2167524512 hasConceptScore W2167524512C159641895 @default.
• W2167524512 hasConceptScore W2167524512C2776235491 @default.
• W2167524512 hasConceptScore W2167524512C2779056158 @default.
• W2167524512 hasConceptScore W2167524512C2779978075 @default.
• W2167524512 hasConceptScore W2167524512C2780192828 @default.
• W2167524512 hasConceptScore W2167524512C2781406297 @default.
• W2167524512 hasConceptScore W2167524512C2909406889 @default.
• W2167524512 hasConceptScore W2167524512C35785553 @default.
• W2167524512 hasConceptScore W2167524512C71924100 @default.
• W2167524512 hasIssue "3" @default.
• W2167524512 hasLocation W21675245121 @default.
• W2167524512 hasLocation W21675245122 @default.
• W2167524512 hasOpenAccess W2167524512 @default.
• W2167524512 hasPrimaryLocation W21675245121 @default.
• W2167524512 hasRelatedWork W1888791395 @default.
• W2167524512 hasRelatedWork W2023255092 @default.
• W2167524512 hasRelatedWork W2101977115 @default.
• W2167524512 hasRelatedWork W2123520623 @default.
• W2167524512 hasRelatedWork W2321621675 @default.
• W2167524512 hasRelatedWork W2737195788 @default.
• W2167524512 hasRelatedWork W3100973536 @default.
• W2167524512 hasRelatedWork W4298839668 @default.
• W2167524512 hasRelatedWork W2498263001 @default.
• W2167524512 hasRelatedWork W3008404431 @default.
• W2167524512 hasVolume "18" @default.
• W2167524512 isParatext "false" @default.

• next